Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects.

MLA

Dewaeles, Edmone, et al. “Istradefylline Protects from Cisplatin-Induced Nephrotoxicity and Peripheral Neuropathy While Preserving Cisplatin Antitumor Effects.” The Journal of Clinical Investigation, vol. 132, no. 22, Nov. 2022. EBSCOhost, https://doi.org/10.1172/JCI152924.

APA

Dewaeles, E., Carvalho, K., Fellah, S., Sim, J., Boukrout, N., Caillierez, R., Ramakrishnan, H., Van der Hauwaert, C., Vijaya Shankara, J., Martin, N., Massri, N., Launay, A., Folger, J. K., de Schutter, C., Larrue, R., Loison, I., Goujon, M., Jung, M., Le Gras, S., … Cauffiez, C. (2022). Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects. The Journal of Clinical Investigation, 132(22). https://doi.org/10.1172/JCI152924

Chicago

Dewaeles, Edmone, Kévin Carvalho, Sandy Fellah, Jaewon Sim, Nihad Boukrout, Raphaelle Caillierez, Hariharan Ramakrishnan, et al. 2022. “Istradefylline Protects from Cisplatin-Induced Nephrotoxicity and Peripheral Neuropathy While Preserving Cisplatin Antitumor Effects.” The Journal of Clinical Investigation 132 (22). doi:10.1172/JCI152924.